<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-143009</identifier>
<setSpec>0213-9626</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Recurrent urinary tract infections from an immunological perspective</dc:title>
<dc:description xml:lang="en">Introduction: Recurrent urinary tract infections (RUTIs) have a high incidence, especially among women. Continuing prophylactic antibiotic treatment for RUTIs is an acceptable practice, although in many cases is not completely effective. Recently, immunoprophylaxis using mucosal bacterial vaccines has emerged as an effective alternative against this pathology. Objective: To review, from an immunological perspective, recurrent urinary tract infections, microbiological aspects and virulence factors of the causative microorganisms, and different prophylactic treatments, mainly immunoprophylaxis. Conclusions: The use of inactivated vaccines, made with whole bacteria or bacterial extracts, administered through mucosal route is presented as a new and effective prophylactic strategy against recurrent urinary tract infection; demonstrating the superiority of the sublingual route, as an optimal route for an appropriate local and distant immunization (AU)</dc:description>
<dc:creator>Sánchez-Ramón, Silvia A</dc:creator>
<dc:creator>Ruiz de la Roja, Juan Carlos</dc:creator>
<dc:creator>Dieli-Crimi, Romina</dc:creator>
<dc:creator>Campo, Julián</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción: Las infecciones recurrentes del tracto urinario (rUTIs) tienen una elevada incidencia, principalmente entre la poblacion femenina. Si bien esta establecido el tratamiento profilactico continuo con antibioticos en las rUTIs, en muchos casos no suele ser efectivo y puede presentar efectos adversos asociados. recientemente, la inmunoprofilaxis mediante el uso de vacunas bacterianas por via mucosa ha surgido como una alternativa eficaz en la prevencion de esta patologia. Objetivo: realizar una revisión, desde una perspectiva inmunologica, de las RUTIs, de los aspectos microbiologicos y factores de virulencia de los microorganismos causales, y de los diferentes tratamientos profilacticos, principalmente de inmunoprofilaxis. Conclusiones: El uso de vacunas inactivadas, formuladas con bacterias enteras o extractos bacterianos, y administradas por via mucosa, se presenta como una nueva y eficaz estrategia profiláctica frente a la recurrencia de la infeccion urinaria; demostrando la superioridad de la via sublingual, como una ruta optima, para una adecuada inmunización local y a distancia (AU)</dc:description>
<dc:source>Inmunología (1987);34(1): 25-28, ene.-mar. 2015. ilus</dc:source>
<dc:identifier>ibc-143009</dc:identifier>
<dc:title xml:lang="es">Infecciones recurrentes del tracto urinario desde una perspectiva inmunología</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d14952^s22038</dc:subject>
<dc:subject>^d55394^s22038</dc:subject>
<dc:subject>^d5017^s22038</dc:subject>
<dc:subject>^d5016^s22022</dc:subject>
<dc:subject>^d14951^s22038</dc:subject>
<dc:subject>^d22203^s22021</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d22203</dc:subject>
<dc:subject>^d12428</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d5016^s22038</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d32857^s22045</dc:subject>
<dc:subject>^d22203^s22038</dc:subject>
<dc:subject>^d32720^s22038</dc:subject>
<dc:subject>^d14951^s22053</dc:subject>
<dc:type>article</dc:type>
<dc:date>201503</dc:date>
</metadata>
</record>
</ibecs-document>
